Craneware

Craneware Conversion FCF

Taux de Conversion FCL (FCL/EBITDA) de Craneware (CRW.L) au 8 oct. 2026 est 213,65 %. L'année précédente, Taux de Conversion FCL (FCL/EBITDA) était 302,13 % — une variation de -29,28 % (plus faible).

Conversion FCF

213,65 %

YoY

-29,28%

Dernière mise à jour:

Taux de Conversion FCL (FCL/EBITDA) de Craneware est 2026 213,65 % . Taux de Conversion FCL (FCL/EBITDA) de Craneware était 2025 302,13 % . Elle diminue ainsi de -29,28% plus faible par rapport à l'année précédente.

L'histoire de Craneware Conversion FCF

  • 3 ans

  • 10 ans

  • 25 ans

  • Max

Conversion FCF
Date
Conversion FCF
1 janv. 2019
20,21 USD
1 janv. 2020
65,10 USD
1 janv. 2021
102,37 USD
1 janv. 2022
137,43 USD
1 janv. 2023
901,18 USD
1 janv. 2024
212,81 USD
1 janv. 2025
302,13 USD
1 janv. 2026
213,65 USD
L'histoire de Craneware Conversion FCF
ANNÉEConversion FCFYoY
213,65 %-29,28%
302,13 %+41,97%
212,81 %-76,39%
901,18 %+555,73%
137,43 %+34,25%
102,37 %+57,24%
65,10 %+222,08%
20,21 %-87,38%
160,13 %+63,17%
98,14 %-19,16%
121,40 %-38,04%
195,92 %+119,22%
89,37 %—
Accéder à ces données via l’API Eulerpool

Craneware Analyse d'actions

Que fait Craneware ? Craneware PLC is a publicly traded company based in Edinburgh, Scotland, specializing in the development and marketing of software solutions for the healthcare industry. The company was founded in 1999 and has been listed on the London Stock Exchange since 2007. Business Model and Products Craneware's business model is based on the development and marketing of software solutions for the healthcare industry that help customers optimize their financial and performance processes. Craneware focuses particularly on the area of Revenue Cycle Management (RCM), which involves the processing of billing and payment processes in hospitals. Craneware's software solutions are used in various areas, including billing processes, pricing, contract management, compliance, and analytics. The products are modular and can be individually configured according to the customer's needs. One example of a product is the Revenue Integrity Management System (RIMS), which allows for comprehensive analysis of patient billing and ensures that hospitals maximize their revenue while complying with regulations. Other products include Reference Plus, which helps customers determine prices for medical services and remain competitive, and the Online Analytics Suite, which specializes in data analysis and reporting. Divisions Craneware is divided into various divisions, including North America, International, and UK & EMEA. North America is the company's largest market, accounting for approximately 90% of its revenue. In North America, Craneware has had a strong presence for many years and works closely with many large hospitals and healthcare organizations. The company's focus on RCM solutions has garnered significant attention here, and many customers appreciate the efficiency and performance of the software solutions. In the International division, Craneware is focused on expanding its presence in Europe, Asia, Africa, and the Middle East. The company has already gained many partners in these regions and is working to further expand its market share. In the UK & EMEA, Craneware primarily serves the NHS hospitals (National Health Service) and offers a wide range of RCM solutions to its customers. History Craneware was founded in 1999 by Gordon Craig, a graduate of the University of Edinburgh. The company's headquarters were established in Edinburgh and quickly grew to become a major employer in the city. In 2007, Craneware was listed on the London Stock Exchange and has been a publicly traded company since then. In 2015, the company was included in the FTSE AIM 100 Index. In recent years, the company has experienced strong growth and expanded its market presence to various countries. Craneware also plans to continue investing in research and development and focusing on innovation in order to provide its customers with the best RCM solutions in the future. Craneware est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action Craneware

Taux de Conversion FCL (FCL/EBITDA) de Craneware s'élève à 213,65 % en 2026.

Taux de Conversion FCL (FCL/EBITDA) de Craneware a changé de 302,13 % à 213,65 %, ce qui représente une variation de -29,28 %. La valeur est plus faible qu'l'année précédente.

Sur Eulerpool, vous trouverez l'évolution historique complète de Craneware de Taux de Conversion FCL (FCL/EBITDA) depuis 2006 – avec des valeurs annuelles, des graphiques et une analyse détaillée.

La conversion FCL mesure l'efficacité avec laquelle l'EBITDA se convertit en flux de trésorerie libre. Une conversion plus élevée indique une allocation de capital efficace et des coûts de maintenance faibles.

Un 'bon' varie selon le secteur et le stade de l'entreprise. Sur Eulerpool, vous pouvez comparer Craneware de Taux de Conversion FCL (FCL/EBITDA) avec les pairs du secteur et la moyenne du secteur pour évaluer son attrait.

Pour évaluer de Taux de Conversion FCL (FCL/EBITDA), il est essentiel de le comparer avec les pairs du même secteur. Sur Eulerpool, vous pouvez trouver des comparaisons directes du secteur pour Taux de Conversion FCL (FCL/EBITDA).

Accéder à ces données via l’API Eulerpool

Flux de trésorerie — Craneware

Toutes les Métriques Clés — Craneware

Croissance